Research & Publications

11
Targeting TFAP2β condensation suppresses the development of esophageal squamous cell carcinoma
Impact Factor:64.5
Journal:Cell
Publication Date:2025-12-16
12
Inhibition of ferroptosis by microbiota‐derived lithocholic acid underlies the intestinal radioprotection of a host defensin‐derived oligopeptide
Impact Factor:33.2
Journal:iMeta
Publication Date:2025-12-15
13
Euphorbia pekinensis glycosphingolipids disrupt gut motility and fluid balance via TRPA1 activation in enterochromaffin cells
Impact Factor:7.7
Journal:BRITISH JOURNAL OF PHARMACOLOGY
Publication Date:2025-10-21
14
SENP3 induced HADHA deSUMOylation enhances intrahepatic cholangiocarcinoma chemotherapy sensitivity via fatty acid oxidation
Impact Factor:9.1
Journal:Cancer Letters
Publication Date:2025-08-10
15
Platelet-derived exosomal LINC00183 facilitate colorectal cancer malignant progression driven by histone lactylation through stabilizing ENO1
Impact Factor:9.6
Journal:Cell Death & Disease
Publication Date:2025-08-07
16
Triptolide targets PPP2CA/ITGA5 axis to suppress lactate-driven ovarian cancer progression
Impact Factor:5.7
Journal:Chinese Medicine
Publication Date:2025-08-06
17
Association of elevated ACSL4 expression with impaired endometrial receptivity in endometriosis and restoration by ACSL4 inhibitor PRGL493
Impact Factor:2.9
Journal:Journal of Reproductive Immunology
Publication Date:2025-07-27
18
Ezetimibe Engineered L14-8 Suppresses Advanced Prostate Cancer by Activating PLK1/TP53-SAT1-Induced Ferroptosis
Impact Factor:14.3
Journal:Advanced Science
Publication Date:2025-06-19
19
Scutellarin suppresses ovarian cancer progression by targeting METTL5
Impact Factor:3.9
Journal:Scientific Reports
Publication Date:2025-05-27
20
Celastrol reduces cisplatin-induced nephrotoxicity by downregulating SNORD3A level in kidney organoids derived from human iPSCs
Impact Factor:4.4
Journal:Frontiers in Pharmacology
Publication Date:2025-03-27

AimingMed is a leading biotech company specializing in organoid technology.Our techniques empower oncologist with organoid-based drug sensitivity tests, and our AI algorithm facilitate the selection of the most suitable treatment options for patients...

Services

Contact

  • Hangzhou AimingMed Technologies Co., Ltd.
    1st Floor, South Block, Building 10, No.88 Jiangling Road, Binjiang District, Hangzhou, Zhejiang Province, P.R.China
  • Chengdu AimingMed Medical Laboratory Co., Ltd.
    1st Floor, Building 5, No.77 Jinke South Road, Jinniu High-tech Industrial Park, Chengdu, Sichuan Province
  • Chengdu Organoids Biobank
    No.1, 1st Floor, Building 5, No.77, Jinke South Second Road, Jinniu High-tech Industrial Park, Chengdu, Sichuan Province, China
  • Shandong Province Organoids Biobank
    Building 16, Blue Medicine Valley Life Island, No. 17, Donghai Road, Dayao Subdistrict, Muping District, Yantai City, Shandong Province, China
  • AimingMed Singapore Pte.Ltd.
    CSSD International Business Cooperation Centre, BLK 55 Ayer Rajah Crescent #01-01, Singapore 139949
  • 0571-85352695
  • info@aimingmed.com